Precigen Stock News & Updates
[WKN: A2PZG1 | Symbol: PGEN]
Precigen: Specialist in Immunotherapies Secures US Market Exclusivity for PAPZIMEOS Until 2032!
Precigen has secured the first and only FDA-approved therapy for the treatment of recurrent respiratory...
Analysts' Top 5 Price Targets of August 15, 2025
TeraWulf [US88080T1043] Citizens JMP reiterates Outperform rating and raises the price target...
- ‹
- 1
- ›